In another in vitro assay, recombinant IL-25 expression, which correlates with both disease severity and IL-4 levels in specific OLP lesion subtypes, was used to stimulate patient-derived CD4+ T cells, leading to a significant IL-4 mRNA production increase [42]. Here, IL4 is linked to oral lichen planus.